Online Learning > COVID-19 Resources > COVID-19 Webinar Series > FDA Regulatory Toolbox

Wednesday, April 22, 2020

FDA Regulatory Toolbox for COVID-19 Response;
Research Highlights: Remdesivir,
Updates from the Front Lines: Florida & India 




FDA Regulatory Toolbox for COVID-19 Response

Elizabeth Sadove, JD

Director of Medical Countermeasures Regulatory Policy,
Office of Counterterrorism and Emerging Threats, Office of Chief Scientist,
Office of the Commissioner, U.S. Food & Drug Administration, Silver Spring, MD                          


Research Highlights: Remdesivir, Hydroxychloroquine & Chloroquine

Charles McKay, MD, FACMT, FACEP

Past President,  American College of Medical Toxicology (ACMT)
Associate Medical Director, CT Poison Control Center
Associate Clinical Professor, University of Connecticut School of Medicine,
Farmington, CT                                                                                                      

Updates From the Front Lines


Miami Beach, FL

David A. Farcy, MD, FAAEM, FCCM

President, American Academy of Emergency Medicine (AAEM);
Chair, Department of Emergency Medicine and
Director of Emergency Medicine Critical Care, Mount Sinai Medical Center,
Miami Beach, FL                                                                                                      


Chandigarh, India

Ashish Bhalla, MD, FACMT

President, Asia Pacific Association of Medical Toxicology (APAMT);
Professor of Medicine, Medical Toxicologist, Post Graduate Institute of
Medical Education and Research, Chandigarh, India                                     



Series Partners

American Academy of Clinical Toxicology (AACT) | American Academy of Emergency Medicine (AAEM) | American Association of Poison Control Centers (AAPCC) | American College of Medical Toxicology (ACMT) | Asia Pacific Association of Medical Toxicologists (APAMT) | European Association of Poison Centers and Clinical Toxicologists (EAPCCT) | Middle East & North Africa Clinical Toxicology Association (MENATOX)  

images/COVID Series LOGOS